Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions

Background and Design: The incidence and distribution of autoimmune subepidermal bullous diseases were estimated from prospective data (including immunoelectron microscopy) obtained from 100 cases during a mean period of 35 months in three university dermatologic centers in Amiens, Limoges, and Tours, France, that correspond to a cumulative reference population of 3.55×10 6 . Results: Using data from these regions, we found a mean annual incidence of autoimmune subepidermal bullous diseases to be 10.4 per million people and, therefore, estimated the overall number of new cases of these disorders in France to be about 590 cases per year. According to clinical and immunoelectron microscopic criteria, a precise diagnosis was established in 94 cases, distributed as follows: bullous pemphigoid, 69 cases; cicatricial pemphigoid, 12 cases; linear IgA dermatosis, five cases; herpes gestationis, four cases; epidermolysis bullosa acquisita, two cases; and vesiculobullous systemic lupus erythematosus, two cases. Conclusion: Our prospective study is the first assessing the incidence and distribution of autoimmune subepidermal bullous disorders that systematically included immunoelectron microscopic data. Our estimated incidence of bullous pemphigoid (seven new cases per million people per year) is large enough to establish bullous pemphigoid as the major autoimmune subepidermal bullous disease for the purpose of therapeutic trials. On the contrary, all other disorders, particularly epidermolysis bullosa acquisita (estimated annual incidence, 0.17 to 0.26 per million people), were very rare and reflect the paucity of patients available for shortterm clinical studies in France. (Arch Dermatol. 1995;131:48-52)

[1]  Y. de Prost,et al.  [Linear IgA dermatosis]. , 1994, La Revue du praticien.

[2]  L. Vaillant,et al.  Specific pruritic diseases of pregnancy : a prospective study of 3192 pregnant women , 1994 .

[3]  D. Murrell,et al.  Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. , 1993, The Journal of investigative dermatology.

[4]  J. Regezi,et al.  Immune-Mediated Subepithelial Blistering Diseases of Mucous Membranes: Pure Ocular Cicatricial Pemphigoid Is a Unique Clinical and Immunopathological Entity Distinct From Bullous Pemphigoid and Other Subsets Identified by Antigenic Specificity of Autoantibodies , 1993 .

[5]  L. Diaz,et al.  Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. , 1992, The Journal of investigative dermatology.

[6]  J. Saurat,et al.  The major cicatricial pemphigoid antigen is a 180-kD protein that shows immunologic cross-reactivities with the bullous pemphigoid antigen. , 1992, The Journal of investigative dermatology.

[7]  J. Saurat,et al.  A prospective immunofluorescence study of 111 cases of pruritic dermatoses of pregnancy: IgM anti‐basement membrane zone antibodies as a novel finding , 1992, The British journal of dermatology.

[8]  E. Bauer,et al.  Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Parry,et al.  Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. , 1991, The Journal of biological chemistry.

[10]  L. Dubertret,et al.  Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. , 1991, The Journal of investigative dermatology.

[11]  W. Saunders,et al.  Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. , 1990, The Journal of clinical investigation.

[12]  T. Nishikawa,et al.  Partial cDNA cloning of the 230-kD mouse bullous pemphigoid antigen by use of a human monoclonal anti-basement membrane zone antibody. , 1990, The Journal of investigative dermatology.

[13]  J. Roujeau,et al.  Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. , 1990, The Journal of investigative dermatology.

[14]  R. Pye,et al.  Recognition of two distinct major antigens by bullous pemphigoid sera , 1990, The British journal of dermatology.

[15]  I. Leigh,et al.  Western blot analysis of the antigen in pemphigoid gestationis , 1990, The British journal of dermatology.

[16]  J. Bystryn,et al.  Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. , 1990, Archives of dermatology.

[17]  C. R. Jones,et al.  Immunochemical characterization of three components of the hemidesmosome and their expression in cultured epithelial cells , 1989, The Journal of cell biology.

[18]  J. Saurat,et al.  Bullous pemphigoid and multiple sclerosis: more than a coincidence? Report of three cases. , 1989, Journal of the American Academy of Dermatology.

[19]  J. Saurat,et al.  Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. , 1989, The Journal of investigative dermatology.

[20]  D. Roop,et al.  Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. , 1988, The Journal of clinical investigation.

[21]  J. Zone,et al.  Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. , 1988, The Journal of clinical investigation.

[22]  L. Dubertret,et al.  Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients. , 1987, The Journal of investigative dermatology.

[23]  C. Grattan Evidence of an association between bullous pemphigoid and psoriasis , 1985, The British journal of dermatology.

[24]  D. Woodley,et al.  Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). , 1985, The Journal of investigative dermatology.

[25]  L. Diaz,et al.  Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. , 1985, Journal of immunology.

[26]  P. Fletcher,et al.  Neurofibromatous dermal hypoplasia: a clinical, pharmacological and ultrastructural study , 1985, The British journal of dermatology.

[27]  D. Woodley,et al.  Epidermolysis bullosa acquisita--a pemphigoid-like disease. , 1984, Journal of the American Academy of Dermatology.

[28]  L. Dubertret,et al.  A routine immuno‐electron microscopic technique for localizing an auto‐antibody on epidermal basement membrane , 1984, The British journal of dermatology.

[29]  E. Shevach,et al.  Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia , 1981, Cell.

[30]  D. Boorsma,et al.  Epidermolysis bullosa acquisita , 1980 .

[31]  W. F. Lever Pemphigus and pemphigoid: A review of the advances made since 1964 , 1979 .

[32]  R. Briggaman,et al.  Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. , 1993, The Journal of investigative dermatology.

[33]  L. Vaillant,et al.  Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. , 1993, Archives of dermatology.

[34]  J. Stanley,et al.  A 230-kD basic protein is the major bullous pemphigoid antigen. , 1989, The Journal of investigative dermatology.

[35]  Y. Takahashi,et al.  A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. , 1985, The Journal of investigative dermatology.

[36]  D. Woodley,et al.  Identification and partial characterization of pemphigoid antigen extracted from normal human skin. , 1984, The Journal of investigative dermatology.

[37]  W. Carter,et al.  Rapid Epiligrin, the Major Human Keratinocyte Integrin Ligand, Is a Target in Both an Acquired Autoimmune and an Inherited Subepidermal Blistering Skin Disease , 2022 .